RAPT Therapeutics RAPT
$ 0.83
2.18%
Quarterly report 2024-Q3
added 11-12-2024
RAPT Therapeutics Cash Flow 2011-2024 | RAPT
Annual Cash Flow RAPT Therapeutics
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-97 M | -70.8 M | -61 M | -40.5 M | -35.5 M | -33 M | - | - | - | - | - | - | - |
Depreciation & Amortization |
1.22 M | 1.05 M | 996 K | 1.12 M | 1.33 M | 1.24 M | - | - | - | - | - | - | - |
Accounts Payables |
5.18 M | 3.36 M | 2 M | 2.38 M | 1.14 M | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow RAPT Therapeutics
2024-Q3 | 2024-Q2 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | - | - | -18.6 M | - | -47.9 M | -30.8 M | -15.6 M | - | -40.3 M | -27.8 M | -13.9 M | - | -25.1 M | -15.2 M | -8.74 M | - | -29.8 M | -17.6 M | -8.63 M | - | -23.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
300 K | 300 K | 300 K | 300 K | 299 K | - | 300 K | 200 K | 261 K | - | 200 K | 200 K | 280 K | - | 300 K | 400 K | 199 K | - | 300 K | 400 K | 331 K | - | 300 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
1.38 M | 2.72 M | 5.3 M | 2.69 M | 8.94 M | 3.36 M | 4.04 M | 4.1 M | 1.94 M | 2 M | 4.02 M | 2.71 M | 3.13 M | 2.38 M | 2.38 M | 2.38 M | 2.38 M | 1.14 M | 1.14 M | 1.14 M | 1.14 M | 1.77 M | 1.77 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5.01 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency